News

Jefferies Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
In a report released on April 4, Stephen Barker from Jefferies maintained a Buy rating on Sumitomo Dainippon Pharma Co (DNPUF – Research ...
pharmaphorum5y
Sumitomo, Roivant close $3 billion deal, forming Sumitovant
A new international biotech – Sumitovant Biopharma – has been created after Sumitomo Dainippon’s strategic alliance with Roivant Sciences came to fruition as 2019 drew to a close.